Net revenue for Q2 2026 was $950.3 million, a 5.8% increase compared to Q2 2025. Net income attributable to H.B. Fuller rose to $67.8 million in Q2 2026 from $41.8 million in Q2 2025. Diluted earnings per share (EPS) for Q2 2026 was $1.23, compared to $0.76 in the prior year period. Adjusted EBITDA for Q2 2026 increased 9.3% to $181.0 million. The company announced a recommended cash offer to acquire Advanced Medical Solutions Group plc for approximately 659 million British pounds. The company secured up to $3.0 billion in bridge credit facilities to fund the pending acquisition.